Technical snag forces Doha-bound AIE flight to return to Mangaluru 

Mangaluru, May 28: As many as 19 labourers, who were stranded in Lakshadweep island due to lockdown following COVID-19 outbreak, have been brought back to Mangaluru by a boat ' Amindivi' on Thursday.

On their arrival, they were subjected to medical examination and were warmly welcomed by their family members who had come to receive them at the Port.

Bengaluru, May 8: Karnataka Minister for Primary and Secondary Education S Suresh Kumar on Friday said that the next academic year will have to be shortened as it will delayed due to the COVID-19.

Mr Kumar in a meeting with Education Department officials said that the syllabus and curriculum for the academic year will have to be designed according to time available. Additional content in the syllabus will have to be removed, according to a statement issued here by the education department here on Friday.

The Minister also stated that plans are underway to conduct CET examination meant for admission into professional courses immediately after the SSLC examination.

He also advised the officials to make the Department’s YouTube channel feature more subject-wise and chapter-wise content for the aid of the students.

Additionally, a booklet will be launched to teach students on how to adjust to life in the post-COVID-19 world.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.